352 related articles for article (PubMed ID: 9779299)
1. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(5):533-40. PubMed ID: 9779299
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
3. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
5. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
[TBL] [Abstract][Full Text] [Related]
7. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
[TBL] [Abstract][Full Text] [Related]
8. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
Mamehara A; Sugimoto T; Sugiyama D; Morinobu S; Tsuji G; Kawano S; Morinobu A; Kumagai S
Kobe J Med Sci; 2010 Sep; 56(3):E98-107. PubMed ID: 21063156
[TBL] [Abstract][Full Text] [Related]
9. [The levels of FDP, FDP-E and D-dimer in patients with rheumatoid arthritis].
Nakashima M; Aoyagi T; Aratake K; Kawabe Y; Eguchi K
Ryumachi; 1998 Dec; 38(6):793-800. PubMed ID: 10047717
[TBL] [Abstract][Full Text] [Related]
10. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.
Shinozaki M; Inoue E; Nakajima A; Hara M; Tomatsu T; Kamatani N; Yamanaka H
Mod Rheumatol; 2007; 17(5):403-8. PubMed ID: 17929133
[TBL] [Abstract][Full Text] [Related]
11. Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis.
Xue L; Tao L; Li X; Wang Y; Wang B; Zhang Y; Gao N; Dong Y; Xu N; Xiong C; Zhou T; Liu Z; Liu H; He J; Li K; Geng Y; Li M
Sci Rep; 2021 Aug; 11(1):16903. PubMed ID: 34413382
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
Keenan RT; Swearingen CJ; Yazici Y
Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
[TBL] [Abstract][Full Text] [Related]
13. Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage.
Skacelova M; Hermanova Z; Horak P; Ahmed K; Langova K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):296-302. PubMed ID: 28461705
[TBL] [Abstract][Full Text] [Related]
14. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
Viswanath V; Myles A; Dayal R; Aggarwal A
J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500
[TBL] [Abstract][Full Text] [Related]
15. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation.
Manicourt DH; Fujimoto N; Obata K; Thonar EJ
Arthritis Rheum; 1995 Aug; 38(8):1031-9. PubMed ID: 7639798
[TBL] [Abstract][Full Text] [Related]
16. Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.
Galil SM; El-Shafey AM; Hagrass HA; Fawzy F; Sammak AE
Int J Rheum Dis; 2016 Apr; 19(4):377-84. PubMed ID: 25292349
[TBL] [Abstract][Full Text] [Related]
17. The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.
Toubi E; Kessel A; Grushko G; Sabo E; Rozenbaum M; Rosner I
Clin Exp Rheumatol; 2002; 20(2):221-4. PubMed ID: 12051403
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
J Rheumatol; 2000 Dec; 27(12):2761-8. PubMed ID: 11128661
[TBL] [Abstract][Full Text] [Related]
19. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis.
Yoshihara Y; Obata K; Fujimoto N; Yamashita K; Hayakawa T; Shimmei M
Arthritis Rheum; 1995 Jul; 38(7):969-75. PubMed ID: 7612046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
